Introduction
============

Diarrheal outbreaks are serious concerns all over the world particularly in the developing countries due to inadequate sanitation systems \[[@R1]\]. In most of the cases, the enteric infections originated due to the intake of less cooked food and contaminated water \[[@R2]\]. Several strains of *Shigella* \[[@R3]\], *Salmonella* \[[@R4]\] and enteropathogenic *Escherichia coli* \[[@R5]\] are commonly known for causing diarrheal infections. Besides the mainstream enteropathogenic bacterium, *Escherichia albertii* (*E. albertii*) is an emerging human pathogen causing gastroenteric infections in different countries \[[@R6]\]. Although, this species was identified earlier as *Hafnia alvei*, later it was redesignated as *E. albertii* \[[@R7]\]. *E. albertii* acted as a causative agent for diarrheal diseases in children with vomiting, fever and abdominal distension \[[@R8]\]. Several strains of *E. albertii* have been identified till date, which significantly contributed to the spreading of devastating diarrheal infections in different countries \[[@R9]\]. The role of cell wall O-polysaccharides in regulating the virulence properties of bacteria is well established \[[@R10]\]. Recently, Naumenko et al. \[[@R11]\] reported the structure of the repeating unit of the cell wall O-polysaccharide of the *E. albertii* O4 strain \[[@R11]\], which is a pentasaccharide comprising of α-linked ᴅ-galactosamine, β-linked ᴅ-glucosamine, β-linked ᴅ-galactose, α-linked ʟ-fucose and α-linked ʟ-rhamnose moieties. In the recent past, several vaccine candidates have been developed to control bacterial infections by conjugating cell wall polysaccharides with suitable proteins, which include vaccines against *Haemophilia influenza* type b (Hib) \[[@R12]--[@R13]\], meningitis \[[@R14]\], pneumococcal infections \[[@R15]--[@R16]\] and enteric diseases such as cholera \[[@R17]\], diarrhea \[[@R18]\] and urinary tract infections \[[@R19]\]. Despite the possibility of isolating the polysaccharides by fermentation techniques, it is difficult to get a significant quantity of polysaccharide fragments from natural sources with adequate purity. Therefore, the development of chemical synthetic strategies is quite pertinent to obtain a requisite quantity of oligosaccharide fragments with adequate purity. In this direction, the total synthesis of the pentasaccharide repeating unit corresponding to the cell wall O-antigenic polysaccharide of the *E. albertii* O4 strain using a sequential glycosylation strategy is presented herein ([Fig. 1](#F1){ref-type="fig"}).

![Structure of the pentasaccharide repeating unit corresponding to the cell wall O-antigen of *Escherichia albertii* O4 and its synthetic intermediates.](Beilstein_J_Org_Chem-16-106-g002){#F1}

Results and Discussion
======================

The synthesis of pentasaccharide **1** was achieved using a convergent as well as a block synthetic strategy. For this purpose, a series of suitably functionalized monosaccharide intermediates **2** \[[@R20]\], **3** \[[@R21]\], **4** \[[@R22]\], **5** \[[@R23]\], **6** \[[@R24]\] and **7** \[[@R25]\] were prepared from the commercially available reducing sugars utilizing the reaction conditions reported in the literature ([Fig. 1](#F1){ref-type="fig"}). Although the monosaccharide intermediates used for the construction of the pentasaccharide derivative **15** are known in the literature, preparation of these intermediates required multiple step reaction sequences. Having obtained the monosaccharide intermediates, it was decided to proceed through a step-economic block synthetic strategy to achieve the target pentasaccharide derivative. Accordingly, stereoselective glycosylation of a ᴅ-galactosamine derivative **2** with a ᴅ-galactose thioglycoside derivative **3** in the presence of a combination \[[@R26]--[@R27]\] of *N*-iodosuccinimide (NIS) and perchloric acid supported over silica (HClO~4~/SiO~2~) \[[@R28]--[@R29]\] furnished disaccharide derivative **8** in 79% yield, which on de-O-acetylation using sodium methoxide \[[@R30]\] gave the disaccharide acceptor **9** in 95% yield. NMR spectral analysis of compound **9** confirmed its formation with appropriate configuration at the glycosidic linkages \[Signals at δ 5.54 (d, *J* = 2.5 Hz, H-1~A~), 5.44 (s, PhC*H*), 4.54 (d, *J* = 7.5 Hz, H-1~B~) in ^1^H NMR and at δ 105.2 (C-1~B~), 100.6 (Ph*C*H), 98.2 (C-1~A~) in ^13^C NMR spectra\] ([Scheme 1](#C1){ref-type="fig"}).

![(a) NIS, HClO~4~/SiO~2~, MS 4 Å, CH~2~Cl~2~, −45 °C, 1 h, 79%; (b) 0.1 M CH~3~ONa, CH~3~OH, room temperature, 2 h, 95%.](Beilstein_J_Org_Chem-16-106-g003){#C1}

In another experiment, ʟ-rhamnosyl trichloroacetimidate donor **5** was coupled with ʟ-fucosyl thioglycoside acceptor **4** in the presence of HClO~4~/SiO~2~ \[[@R31]\] as activator using an orthogonal glycosylation approach to furnish disaccharide thioglycoside derivative **10** in 76% yield, which was directly used in the next level of glycosylation. NMR spectral analysis of compound **10** unambiguously confirmed its formation \[signals at δ 5.26 (d, *J* = 1.5 Hz, H-1~D~), 4.23 (d, *J* = 9.5 Hz, H-1~C~) in ^1^H NMR and at δ 98.4 (C-1~D~), 84.8 (C-1~C~) in ^13^C NMR spectra\] ([Scheme 2](#C2){ref-type="fig"}). It is worth noting that sulfide linkage at the anomeric position of compound **4** remained unaffected under the reaction conditions.

![(a) HClO~4~/SiO~2~, CH~2~Cl~2~, −10 °C, 1 h, 76%.](Beilstein_J_Org_Chem-16-106-g004){#C2}

Having achieved the disaccharide acceptor **9** and the disaccharide thioglycoside donor **10**, a stereoselective glycosylation between them was attempted in the presence of a combination \[[@R26]--[@R27]\] of NIS and HClO~4~/SiO~2~ as thiophilic activator. Unfortunately, the required tetrasaccharide derivative **11** was obtained in a poor yield (22%, [Scheme 3](#C3){ref-type="fig"}). It was decided to follow a sequential glycosylation strategy to achieve a significant quantity of compound **11**. Accordingly, a stereoselective glycosylation was carried out using compound **9** with ʟ-fucose thioglycoside derivative **6** in the presence of a combination \[[@R26]--[@R27]\] of NIS and HClO~4~/SiO~2~ as thiophilic activator. Gratifyingly, the trisaccharide derivative **12** was obtained in 74% yield with a newly formed 1,2-*cis* glycosyl linkage in it. The structural confirmation of compound **12** was established by its NMR spectral analysis \[signals at δ 5.67 (d, *J* = 3.0 Hz, H-1~A~), 5.60 (d, *J* = 3.5 Hz, H-1~C~), 5.50 (s, PhC*H*), 4.79 (d, *J* = 7.5 Hz, H-1~B~) in ^1^H NMR and at δ 103.3 (C-1~B~), 100.8 (Ph*C*H), 99.0 (C-1~A~), 97.1 (C-1~C~) in ^13^C NMR spectra\]. Compound **12** was subjected to a set of reactions consisting of a one-pot \[[@R32]\] de-O-acetylation and benzylation using benzyl bromide and sodium hydroxide in the presence of tetrabutylammonium bromide (TBAB) followed by oxidative removal \[[@R33]\] of the PMB group using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to give trisaccharide acceptor **13** in 72% yield. Trisaccharide acceptor **13** was then allowed to couple with ʟ-rhamnosyl trichloroacetimidate donor **5** in the presence of HClO~4~/SiO~2~ as a solid acid activator \[[@R31]\] to provide tetrasaccharide derivative **11** in 76% yield, which was de-O-acetylated to furnish tetrasaccharide acceptor **14** in 94% yield. The formation of compound **11** with appropriate configuration at the glycosidic linkages was supported by its NMR spectral analysis \[signals at δ 5.72 (d, *J* = 3.5 Hz, H-1~A~), 5.58 (d, *J* = 3.5 Hz, H-1~C~), 5.51 (s, PhC*H*), 4.80 (d, *J* = 7.5 Hz, H-1~B~), 4.71 (br s, H-1~D~) in ^1^H NMR and at δ 103.3 (C-1~B~), 100.6 (Ph*C*H), 99.0 (C-1~C~), 95.0 (C-1~A~), 94.1 (C-1~D~) in ^13^C NMR spectra\]. Finally, NIS and HClO~4~/SiO~2~-promoted stereoselective glycosylation of compound **14** with ᴅ-glucosamine thioglycoside donor **7** furnished the desired pentasaccharide derivative **15** in 70% yield. The formation of compound **15** with appropriate configuration at the glycosidic linkages was supported by its NMR spectral analysis \[signals at δ 5.64 (d, *J* = 3.5 Hz, H-1~A~), 5.54 (d, *J* = 3.0 Hz, H-1~C~), 5.50 (d, *J* = 8.5 Hz, H-1~E~), 5.48 (s, PhC*H*), 5.41 (s, PhC*H*), 4.96 (br s, H-1~D~), 4.69 (d, *J* = 8.0 Hz, H-1~B~) in ^1^H NMR and at δ 103.4 (C-1~B~), 101.6, 100.4 (2 C, 2 Ph*C*H), 100.1 (C-1~E~), 99.0 (C-1~C~), 94.9 (C-1~D~), 94.7 (C-1~A~) in ^13^C NMR spectra\]. Compound **15** was subjected to a sequence of reactions consisting of (i) reductive transformation of the azido group into an acetamido group by the treatment with thioacetic acid \[[@R34]\]; (ii) transformation of the *N*-phthalimido group into acetamido group using hydrazine hydrate followed by selective N-acetylation \[[@R35]\]; (iii) hydrogenolysis of benzyl ethers and benzylidene acetals over Pearlman's catalyst \[[@R36]\] to furnish the desired pentasaccharide **1** in 49% overall yield ([Scheme 4](#C4){ref-type="fig"}). The structure of compound **1** was unambiguously characterized by its NMR spectral analysis \[signals at δ 5.37 (d, *J* = 2.0 Hz, H-1~A~), 5.29 (d, *J* = 3.5 Hz, H-1~C~), 5.12 (br s, H-1~D~), 4.73 (d, *J* = 7.5 Hz, H-1~E~), 4.61 (d, *J* = 8.0 Hz, H-1~B~) in ^1^H NMR and at δ 102.2 (C-1~E~), 102.1 (C-1~B~), 96.8 (C-1~A~), 96.5 (C-1~C~), 96.0 (C-1~D~) in ^13^C NMR spectra\].

![(a) NIS, HClO~4~/SiO~2~, MS 4 Å, CH~2~Cl~2~, −40 °C, 1 h, 22%.](Beilstein_J_Org_Chem-16-106-g005){#C3}

![(a) NIS, HClO~4~/SiO~2~, MS 4 Å, CH~2~Cl~2~, −45 °C, 1 h, 74%; (b) BnBr, NaOH, TBAB, THF, room temperature, 6 h; (c) DDQ, CH~2~Cl~2~/H~2~O (9:1), room temperature, 2 h, 72% in two steps; (d) HClO~4~/SiO~2~, CH~2~Cl~2~, −10 °C, 1 h, 76%; (e) 0.1 M CH~3~ONa, CH~3~OH, room temperature, 2 h, 94%; (f) NIS, HClO~4~/SiO~2~, MS 4 Å, CH~2~Cl~2~, --15 °C, 1 h, 70%; (g) CH~3~COSH, pyridine, room temperature, 16 h; (h) NH~2~NH~2~·H~2~O, EtOH, 80 °C, 12 h; (i) Ac~2~O, CH~3~OH, room temperature, 30 min; (j) H~2~, 20%-Pd(OH)~2~/C, CH~3~OH, room temperature, 24 h, 49% in four steps.](Beilstein_J_Org_Chem-16-106-g006){#C4}

Conclusion
==========

In summary, a convenient stepwise synthetic strategy has been developed for the synthesis of the pentasaccharide repeating unit of the cell wall O-antigen of *Escherichia albertii* O4 in very good yield. Although the target compound can be achieved by block synthetic approach but a better yield of the product was obtained by a sequential approach. HClO~4~/SiO~2~ was used as a solid acid activator in the glycosylation reactions using trichloroacetimidate as well as thioglycoside donors. All intermediate steps were high yielding with excellent stereo outcome in the glycosidic linkages.
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